Rhenovia Pharma Language Contact
Search
   
       
    Rhenovia Pharma    
   
RSS

Stay connected & subscribe to Rhenovia News Feed

2 April 2012 - Rhenovia to BioCentury: Simultaneous launch of Orphan Disease Biosimulation Platforms and 2nd Round Table for Investors

Rhenovia to BioCentury: Simultaneous launch of Orphan Disease Biosimulation Platforms and 2nd Round Table for Investors

 

 

 

Rhenovia Pharma SAS (Mulhouse, France) and Rhenovia Development Inc. (Cambridge, MA, USA)

 

April 2nd, 2012

In an interview to BioCentury Serge Bischoff, PhD, President & CEO reveals the simultaneous launch of new biosimulation drug discovery programs for Huntington Disease and Duchenne muscular dystrophies as well as of a second round table of fund raising by external investors of $4 million.

 

Thank you for contacting Dr. Serge Bischoff, at info@rhenovia.com

 

Rhenovia 120402 BioCentury.pdf